Conference Coverage

Which infants with invasive bacterial infections are at risk for adverse outcomes?


 

REPORTING FROM PAS 2018


Dr. Pruitt acknowledged certain limitations of the study, including its retrospective design, that the outcomes were limited to 30 days, and the fact that the findings may not be generalizable to nontertiary settings. “Our findings have important implications for the care of infants with invasive bacterial infections,” he concluded. “In particular, the high rate of adverse outcomes for infants with bacterial meningitis can provide some context for clinicians in assessing the need for diagnostic evaluation for invasive bacterial infection and discussing testing and treatment with parents. Our findings may also help to inform inpatient management for hospitalized infants with invasive bacterial infections, as well as anticipatory guidance for parents, particularly around follow-up. Further prospective studies evaluating the long-term outcomes of infants with invasive bacterial infections are needed.”

The study was supported in part by a grant from the National Institutes of Health. Dr. Pruitt reported having no financial disclosures.

Pages

Recommended Reading

About sex, adults aren’t talking or kids aren’t listening
MDedge Pediatrics
Cochrane report: HPV vaccine proves its worth in adolescent, young adult women
MDedge Pediatrics
Emotional regulation training lowers risk of adolescents having sex
MDedge Pediatrics
Zika topped Lyme in 2016
MDedge Pediatrics
Analysis finds inconsistent uptake of meningococcal B vaccines
MDedge Pediatrics
CAZ-AVI appears safe, effective in pediatric complicated UTI, intra-abdominal infections
MDedge Pediatrics
MDedge Daily News: Do HPV vaccines really cut cancer risk?
MDedge Pediatrics
FDA seeks comments on pediatric HIV product development
MDedge Pediatrics
ADHD, asthma Rxs up
MDedge Pediatrics
Persistent providers sway parents to accept HPV vaccination
MDedge Pediatrics